Mark Knafl

10PUBLICATIONS
63CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Information extraction and fusionPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2025
Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine Tumors.

Reed I Ayabe, Y David Seo, Brenda Melendez

|Apr 27, 2025
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial.

Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu

|Feb 28, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal.

Van K Morris, Suyu Liu, Kangyu Lin

|Nov 18, 2024
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer.

Xiaoping Wang, Li Zhao, Xingzhi Song

|May 17, 2024
Automated, High-Throughput Platform to Generate a High-Reliability, Comprehensive Rectal Cancer Database.

Neal Bhutiani, Mahmoud M G Yousef, Abdelrahman Yousef

|May 06, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.

Nicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes

Pageof 2

Frequent Collaborators

4 joint publications

John Paul Shen

4 joint publications

Daniel M Halperin

4 joint publications

Scott Woodman

4 joint publications

Abdelrahman Yousef